Evolutionary genetic analyses of MEF2C gene: Implications for learning and memory in Homo sapiens

Asian Journal of Psychiatry

Volumn 6, Issue 1, 2013, Pages 56-59

  Kalmady, Sunil V ^a   Venkatasubramanian, Ganesan ^a   Arasappa, Rashmi ^a   Rao, Naren P ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Evolution; Hippocampus; Learning; MEF2C; Memory

Indexed keywords

MYOCYTE ENHANCER FACTOR 2; MYOCYTE ENHANCER FACTOR 2C; UNCLASSIFIED DRUG;

ARTICLE; CODON; GENE; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; LEARNING; MAMMALIAN GENETICS; MEF2C GENE; MEMORY; MOLECULAR EVOLUTION; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL;

ANIMALS; EVOLUTION, MOLECULAR; HUMANS; MADS DOMAIN PROTEINS; MAMMALS; MYOGENIC REGULATORY FACTORS; SELECTION, GENETIC;

EID: 84873104846     PISSN: 18762018     EISSN: 18762026     Source Type: Journal    
DOI: 10.1016/j.ajp.2012.08.007     Document Type: Article

References (24)

1. Anisimova M., Liberles D.A. The quest for natural selection in the age of comparative genomics. Heredity 2007, 99(6):567-579.
2. Barbosa A.C., Kim M.S., Ertunc M., Adachi M., Nelson E.D., McAnally J., Richardson J.A., Kavalali E.T., Monteggia L.M., Bassel-Duby R., Olson E.N. MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(27):9391-9396.
3. Calzavara M.B., Medrano W.A., Levin R., Kameda S.R., Andersen M.L., Tufik S., Silva R.H., Frussa-Filho R., Abilio V.C. Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia?. Schizophrenia Bulletin 2009, 35(4):748-759.
4. Flavell S.W., Cowan C.W., Kim T.K., Greer P.L., Lin Y., Paradis S., Griffith E.C., Hu L.S., Chen C., Greenberg M.E. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 2006, 311(5763):1008-1012.
5. Harrison P.J. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology 2004, 174(1):151-162.
6. Holt D.J., Lebron-Milad K., Milad M.R., Rauch S.L., Pitman R.K., Orr S.P., Cassidy B.S., Walsh J.P., Goff D.C. Extinction memory is impaired in schizophrenia. Biological Psychiatry 2009, 65(6):455-463.
7. Hunt P.S. Neonatal treatment with a competitive NMDA antagonist results in response-specific disruption of conditioned fear in preweanling rats. Psychopharmacology 2006, 185(2):179-187.
8. Katoh K., Kuma K., Toh H., Miyata T. MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Research 2005, 33(2):511-518.
9. Kim J.J., Fanselow M.S. Modality-specific retrograde amnesia of fear. Science 1992, 256(5057):675-677.
10. Leifer D., Golden J., Kowall N.W. Myocyte-specific enhancer binding factor 2C expression in human brain development. Neuroscience 1994, 63(4):1067-1079.
11. Li Y.L., Leifer D. Expression of MEF2C by subsets of neocortical and hippocampal neurons. Biological Psychiatry 1996, 39:585-586.
12. Lyons G.E., Micales B.K., Schwarz J., Martin J.F., Olson E.N. Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. Journal of Neuroscience 1995, 15(8):5727-5738.
13. Maren S., Hobin J.A. Hippocampal regulation of context-dependent neuronal activity in the lateral amygdala. Learning and Memory 2007, 14(4):318-324.
14. Matrisciano F., Tueting P., Dalal I., Kadriu B., Grayson D.R., Davis J.M., Nicoletti F., Guidotti A. Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice. Neuropharmacology 2012, 10.1016/j.neuropharm.2012.04.013.
15. Murphy W.J., Eizirik E., Johnson W.E., Zhang Y.P., Ryder O.A., O'Brien S.J. Molecular phylogenetics and the origins of placental mammals. Nature 2001, 409(6820):614-618.
16. Nielsen A.H., Yongsiri C., Hvitved-Jacobsen T., Vollertsen J. Simulation of sulfide buildup in wastewater and atmosphere of sewer networks. Water Science and Technology 2005, 52(3):201-208.
17. Ohman A. Has evolution primed humans to " beware the beast" ?. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(42):16396-16397.
18. Phillips R.G., LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behavioral Neuroscience 1992, 106(2):274-285.
19. Pond S.L., Frost S.D., Muse S.V. HyPhy: hypothesis testing using phylogenies. Bioinformatics 2005, 21(5):676-679.
20. Toriumi K., Mouri A., Narusawa S., Aoyama Y., Ikawa N., Lu L., Nagai T., Mamiya T., Kim H.C., Nabeshima T. Prenatal NMDA receptor antagonism impaired proliferation of neuronal progenitor, leading to fewer glutamatergic neurons in the prefrontal cortex. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2012, 37(6):1387-1396.
21. Yang Z. PAML 4: phylogenetic analysis by maximum likelihood. Molecular Biology and Evolution 2007, 24(8):1586-1591.
22. Yang Z., Wong W.S., Nielsen R. Bayes empirical bayes inference of amino acid sites under positive selection. Molecular Biology and Evolution 2005, 22(4):1107-1118.
23. Yoon S.C., Ahn Y.M., Jun S.J., Kim Y., Kang U.G., Park J.B., Kim Y.S. Region-specific phosphorylation of ERK5-MEF2C in the rat frontal cortex and hippocampus after electroconvulsive shock. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2005, 29(5):749-753.
24. Zhang J., Nielsen R., Yang Z. Evaluation of an improved branch-site likelihood method for detecting positive selection at the molecular level. Molecular Biology and Evolution 2005, 22(12):2472-2479.